Literature DB >> 9927319

Dehydroepiandrosterone: biosynthesis and metabolism in the brain.

I H Zwain1, S S Yen.   

Abstract

Dehydroepiandrosterone (DHEA) is abundantly found in brain tissues of several species, including human. However, the cellular origin and pathway by which DHEA is synthesized in brain are not yet known. We have, therefore, initiated pilot experiments to explore gene expression of cytochrome P450 17alpha-hydroxylase (P450c17), the key steroidogenic enzyme for androgen synthesis, and evaluate DHEA production by highly purified astrocytes, oligodendrocytes, and neurons. Using RT-PCR, we have demonstrated for the first time that astrocytes and neurons in the cerebral cortex of neonatal rat brain express P450c17. The presence of P450c17 in astrocytes and neurons was supported by the ability of these cells to metabolize pregnenolone to DHEA in a dose-dependent manner as determined by RIA. These data were further confirmed by production of androstenedione by astrocytes using progesterone as a substrate. However, cortical neurons express a low transcript of P450c17 messenger RNA and produce low levels of DHEA and androstenedione compared with astrocytes. Oligodendrocytes neither express the messenger RNA nor produce DHEA. The production of DHEA by astrocytes is not limited to cerebral cortex, as hypothalamic astrocytes produce DHEA at a level 3 times higher than that produced by cortical astrocytes. Cortical and hypothalamic astrocytes also have the capacity to metabolize DHEA to testosterone and estradiol in a dose-dependent manner. However, hypothalamic astrocytes were 3 times more active than cortical astrocytes in the metabolism of DHEA to estradiol. In conclusion, our data presented evidence that astrocytes and neurons express P450c17 and synthesize DHEA from pregnenolone. Astrocytes also have the capacity to metabolize DHEA into sex steroid hormones. These data suggest that as in gonads and adrenal, DHEA is biosynthesized in the brain by a P450c17-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927319     DOI: 10.1210/endo.140.2.6528

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  33 in total

Review 1.  Dehydroepiandrosterone sulfate and longevity: new clues for an old friend.

Authors:  S S Yen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

Review 2.  Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways.

Authors:  Rémy Schlichter; Anne Florence Keller; Mathias De Roo; Jean-Didier Breton; Perrine Inquimbert; Pierrick Poisbeau
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

4.  Dehydroepiandrosterone restoration of growth hormone gene expression in aging female rats, in vivo and in vitro: evidence for actions via estrogen receptors.

Authors:  Mary Iruthayanathan; Yi-Hong Zhou; Gwen V Childs
Journal:  Endocrinology       Date:  2005-09-08       Impact factor: 4.736

Review 5.  Recent advances in behavioral neuroendocrinology: insights from studies on birds.

Authors:  James L Goodson; Colin J Saldanha; Thomas P Hahn; Kiran K Soma
Journal:  Horm Behav       Date:  2005-11       Impact factor: 3.587

Review 6.  Insights into rapid modulation of neuroplasticity by brain estrogens.

Authors:  Deepak P Srivastava; Kevin M Woolfrey; Peter Penzes
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

7.  Synergistic effects of dehydroepiandrosterone and retinoic acid on granulocytic differentiation of human promyelocytic NB4 cells.

Authors:  Masami Nakatsu; Masaru Doshi; Kumiko Saeki; Akira Yuo
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

8.  Perimenopausal regulation of steroidogenesis in the nonhuman primate.

Authors:  Krystina G Sorwell; Steven G Kohama; Henryk F Urbanski
Journal:  Neurobiol Aging       Date:  2011-06-17       Impact factor: 4.673

Review 9.  Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials.

Authors:  Michael S Ritsner
Journal:  CNS Neurosci Ther       Date:  2010       Impact factor: 5.243

Review 10.  Dehydroepiandrosterone and age-related cognitive decline.

Authors:  Krystina G Sorwell; Henryk F Urbanski
Journal:  Age (Dordr)       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.